|
|
||||||||
CASE REPORTS |
Departments of Obstetrics & Gynecology and Pathology, New Hanover Regional Medical Center, Coastal Area Health Education Center, Wilmington, North Carolina; and Departments of Pathology and Gynecology & Obstetrics, The Johns Hopkins Hospital, Baltimore, Maryland
Address reprint requests to: John L. Powell, MD, Director of Gynecologic Oncology, Coastal Area Health Education Center, PO Box 9025, Wilmington, NC 28402-9025; E-mail: john.powell{at}coastalahec.org.
ABSTRACT
BACKGROUND: We report a case of metastatic endocervical adenocarcinoma that presented as a virilizing ovarian mass in a young pregnant woman and simulated a primary ovarian endometrioid tumor.
CASE: A 34-year-old woman underwent cesarean delivery and right salpingo-oophorectomy at 34 weeks gestation for a 32-cm androgen-producing ovarian mass. The ovarian tumor, initially interpreted as a primary ovarian endometrioid carcinoma, was demonstrated to represent metastatic endocervical endometrioid adenocarcinoma based on detection of human papillomavirus 16 (HPV-16) deoxyribonucleic acid in the tumor by in situ hybridization. The hysterectomy specimen demonstrated an endocervical adenocarcinoma associated with adenocarcinoma in situ that also contained HPV-16.
CONCLUSION: Human papillomavirus is considered an etiological agent in the development of endocervical adenocarcinomas, having been demonstrated in greater than 90% of tumors. In contrast, recent studies have concluded that HPV is unlikely to play an etiological role in ovarian neoplasia. The demonstration of HPV-16 in both the endocervical and ovarian carcinomas in this patient supports the interpretation that the ovarian tumor is a metastasis.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |